card-3216_Biochemistry expert scientific with eyeglasses
Digital innovation

Driving operational improvements and quality of our services

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3242_Scientist using tablet while colleagues working behind
Download our Corporate brochure

We are IQVIA Laboratories, a leading clinical trial laboratory services organization with end-to-end laboratory services and secure, enterprise-wide biospecimen and consent management solutions.

Download
card-3233_Laboratory scientist working at lab with micropipette, and 96 well plate
Corporate Video

Our commitment to customer success is embedded in every facet of our operations.

Learn more
card-3210_Laboratory technicians conduct a series of tests on a chemical analyzer
Science Innovation

Uniquely positioned to shape, validate, and deliver biomarker assessments that strive to improve patient outcomes across diverse Therapeutic Areas

Learn more
card-3216_Biochemistry expert scientific with eyeglasses
Digital Innovation

Driving operational improvements and quality of our services

Learn more
English You are about to exit for another IQVIA country or region specific website Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. Ok Open in new tab Search

Insight

Are You Ready for the In Vitro Diagnostics Regulation (IVDR)?

Recommendations on meeting the IVDR
Home / Insights / Are You Ready for the In Vitro Diagnostics Regulation (IVDR)?

Authors: Caroline Freeman, Principal Consultant, IQVIA, Michael Wienholt, Regulatory Director, IQVIA Laboratories, & Alan Wookey, Companion Diagnostics & Oncology Scientific Advisor, IQVIA Laboratories

Regulations around in vitro diagnostic products (IVDs) are designed to assure safety and effectiveness, leading to improved health of patients. The IVD regulation, or IVDR, has led to changes in the way that the European Union regulates IVDs and the challenges these changes pose to manufacturers. While the principles of the requirements will be familiar to manufacturers that already have products on the market, there will be challenges in meeting the IVDR. This white paper reviews recent changes and provides recommendations for actions to be compliant within the timelines. It addresses requirements on companion diagnostics (CDx), and also looks at opportunities to consider when partnering with a global central laboratory for IVD / CDx development.

Complete the form below to access this white paper